IN SITU CARCINOMA
Clinical trials for IN SITU CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new IN SITU CARCINOMA trials appear
Sign up with your email to follow new studies for IN SITU CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart transplant drug may also fight skin cancer
Disease control CompletedThis study tested whether the drug everolimus can reduce new skin cancers in heart transplant patients who already had skin cancer. 175 participants received either everolimus or standard immunosuppressants. The goal was to see if everolimus lowers the number of new skin tumors n…
Matched conditions: IN SITU CARCINOMA
Phase: PHASE3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New light device could spot skin cancer without a scalpel
Diagnosis CompletedThis study tested a non-invasive device that uses light to classify skin lesions as healthy, actinic keratosis, or carcinoma. Researchers aimed to see if it could help doctors diagnose skin conditions more accurately without needing a biopsy. The study involved 142 adults with su…
Matched conditions: IN SITU CARCINOMA
Phase: NA • Sponsor: Centre Hospitalier Régional Metz-Thionville • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC